Orchestra BioMed Holdings, Inc.
- OBIO
- NASDAQ
- Biotechnology
- Cardiac Neuromodulation
- Drug-Eluting Balloon
- Hypertension Therapy
$5.45
Today −5.05%Quote Oct 16, 2026, 08:00 PM UTC
−5.71%over the last month
Max drawdown −14.2%From 1-month high −14.2%3 months +46.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$327.6M
Quote Oct 16
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$10.75
+97.2% from here
Floor
$5.25
3.7% below price
Where the price sits
6 analysts
Analyst range, low to high
$10.00$13.00
- Price $5.45
- Resistance $5.60
- Consensus $10.75
The price is right under resistance. Analysts' average target sits about 97% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about OBIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
86